Is this us?
"Passengers arriving at Heathrow airport from “red list” countries like the US will be able to pay for Covid-19 tests to beat quarantine, under a pilot expected to be backed by the Department for Transport.
Grant Shapps, the Transport Secretary, has signalled his support for Covid-19 testing as a way to revive flying after it was decimated by the pandemic and is seeking to agree international standards that could allow quarantine-free air travel.
The Daily Telegraph has established that 21 countries including Austria, Iceland, Jersey, Madeira, Thailand, Singapore, Barbados, Jamaica and Japan have already introduced airport tests that can allow some passengers to avoid quarantine if they are negative for Covid-19.
Under the plan, arrivals at Heathrow would have to pay £150 for the Polymerase Chain Reaction (PCR) based swab tests, as used by the NHS and administered in a clinic airside at the airport.
The 90-second test, which takes swabs from throat and nose, produces results in between seven and 24 hours and has a 100 percent accuracy rate, according to medical trials.
They would be expected to quarantine until they got their results, which, provided they were negative, would then exempt them from self-isolating for the remainder of the 14 days. Only arrivals taking the tests and getting an all-clear would be exempt."
No fly's on this one Threeskins. I would be very much surprised if Covid 19 had no detrimental effect whatsoever. However, i am secure in the fact that our core product is the backbone of the company and the driving force for growth. Aside all other products, IONA sales should, imv be unhindered to a large extent by the virus and we should not detract from the main objective to establish the IONA test as the unrivalled standard throughout the world. The present rate of growth for this product alone is astonishing to say the least, and I am particularly interested in where the numbers will be when fully established in the states. The solidity of the pace of growth can be judged by looking back at how fast we acquired new contracts at a time of heavy bombardment, under immense pressure exerted by Illumina's litigation. We tend to forget the main preset concept and goal that was established in the mind of Steven little long before Premaitha. He realised he had a product that could not be superseded and would at some point be the world standard. This in tern means that all alternate NIPT products will eventually become obsolete, leaving us an open market.
"The global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period."
This is where a major difference gives us an advantage Bakky. As far as I am aware, 85% of all false positive/negative results are from mouth swabs. Blood tests are by far the most accurate but take longer for the result.
Certainly not comfortable letting newcomers leave for the wrong reasons. Firstly may I say ColSoul that you definitely made the right decision. The most important position to overcome is the acceptance of timescale. There are many companies out their at the moment that could possibly turn around a fast buck in quick time, "but", and this is crucial, they may have a far higher risk value than what you have here. Reward here is potentially no different, only timescale deters investors from holding. Ask yourself a question - how many companies have you investing in that have low instability and relatively no risk to your hard earned cash. It might help to validate the stability and risk by looking at who is actually invested. You've probably done this already but Bakky quite kindly just posted a link to a free site, Simply Wall Street. It's free so check out "ownership", you'll see a list of big named institutional investors. Plenty of interest from the right people, that's what all companies look for and we have it in abundance. Another point is, it's like anything, if you spend enough time on research you find out things nobody knows, and believe me nobody on here knows what they should. So do your research and you will be reassured that your money is safe and poised for growth.
Just a moment, I could have sworn a sense of humour missed me by a whisker. Yes, you are human after all. I even sense a glint of true Brit bursting through, can't argue with that. I think it was the letter handed over to the finance minister when the Government changed hands in 2010. It read "There's no more money in the bank". That was it, reminded me of that feeling in my gut when I had £1000 on the winning horse at 5/1, then getting that dreaded announcement "OBJECTION".
I suppose we can't win em all Flipper.
Sorry Flipper, disagree with your gloomy view of our economic recovery. This country is far more resilient than you give credit for. There are already signs in the high street that things are getting back to normal. More importantly, we will in a few months be completely rid of the European Union. Completely rid of the ball and chain we've had wrapped around our necks for the last 40 years. Rid of an organisation that held us back, dragged us down and pushed us into a backward future. I'll never forget when the BBC shot themselves in the foot by presenting a programme that showed a UK Hovercraft manufacturer that wanted to fulfil an order for seven Hovercraft's to Brazil but the deal was made uncompetitive due to the 30% levy imposed by the European Union. All that imposition will be gone, and the door to a new massive marketplace will be open. Economically, we are now in the same place were ten years ago when the Labour party brought us to the point of bankruptcy. The only difference is that this Government had no control over the virus where as the former was a deliberate act of treachery. This country has a bright economic future and now with the right man at the helm and International companies like Yourgene driving forward, I believe we will be back on our feet in no time.
Whats worrying is their revenue growth is based upon only 22% per year. Worrying in the sense that this analysis is based upon audited accounts from September last year with the omission of everything to date. How much is this really undervalued. Not only that, how much undervalued would this be if break even is declared. Twix.
JAdam - your in that gloomy mood again. I suggest you stay off the valium for a few days, then repaint your ceilings white instead of grey. Done trick for me (just joking).
To be honest, you know I agree wholeheartedly with your view on marketing the product. However, marketing imv is essential, but in general has a short term impact. It is the underlying fundamentals that, over time, relate to the accurate level of capitalisation (ie, share price).
To give you an idea of the possible rate of which this company could expand - Illumina hold 75% of the NIPT marketplace in the US, most of which are potentially new clients us. Elucigene have over a number of years established a firm marketplace for it's own products. These are in fact ready made clients/agents available to promote the sale of the IONA nx. In addition, they are sales pitched with an incredible advantage of 99% accuracy compared to 83% of the nearest competitor. Not a bad standpoint to sell your goods I'm sure you will agree. 75% of all platforms in Europe are Illumina and we already have a good number of them in the bag. Imv the surge in sales will be breathtaking.
Bakky - this is where LR's prowess comes into play. I believe the grounds have already been laid in preparation for the CE mark result and much of the work already completed. Many of the clients we would have acquired years ago but were deterred because of the litigation will in fact be ready and waiting to sign on the dotted line.
Andy - that bar steward ran off with our treasured product never to be seen again.
Eato - Look, this share is definitely not just ticking along. It is unfortunately locked into a share price position governed by the brokers rating. Our next final results will include the un-audited three months trading from March with a projection of the following three months to September. Those figures will force the broker to re-rate. We then should see a significant difference in trading range. Further to this I am expecting a second re-assessment by the broker in September based upon the figures showing first uptake of the new IONA nx on the Illumina platform with projections.
Cooper, we have give credit to JAdams and Natdan for that matter. You have to admit this RNS was seriously lacking in it's interpretation of the potential this CE mark can bring. You could say we are wrong to assume the CE mark is accepted in the US and this is a reason not to mention the US at all. In that case they should have mentioned the procedure undertaken to move forward into the US market, but no, nothing. Maybe 75% of the European marketplace operates on the Illumina platform and this is just a run of the mill, everyday point to have no significance and to go unnoticed, but my god there are ways of telling this to the world and this certainly isn't it. I'll forgive his albeit slightly over-zealously negative approach but JAdam has a reasoned overall view of how this RNS was presented and on that point I have to make him right.
Well, you can't argue with that clear cut message. We are recruiting specifically for Covid 19 production and NHS testing. That can only mean additional income over and above NIPT and other products. It seems the July finals are looking very promising indeed. Good find Mala.